Cell cycle control in cancer

HK Matthews, C Bertoli, RAM de Bruin - Nature reviews Molecular cell …, 2022 - nature.com
Cancer is a group of diseases in which cells divide continuously and excessively. Cell
division is tightly regulated by multiple evolutionarily conserved cell cycle control …

Second-generation antimitotics in cancer clinical trials

P Novais, PMA Silva, I Amorim, H Bousbaa - Pharmaceutics, 2021 - mdpi.com
Mitosis represents a promising target to block cancer cell proliferation. Classical antimitotics,
mainly microtubule-targeting agents (MTAs), such as taxanes and vinca alkaloids, are …

Single-chromosomal gains can function as metastasis suppressors and promoters in colon cancer

A Vasudevan, PS Baruah, JC Smith, Z Wang… - Developmental Cell, 2020 - cell.com
High levels of cancer aneuploidy are frequently associated with poor prognosis. To examine
the relationship between aneuploidy and cancer progression, we analyzed a series of …

Identification of key genes related to lung squamous cell carcinoma using bioinformatics analysis

M Gao, W Kong, Z Huang, Z Xie - International journal of molecular …, 2020 - mdpi.com
Lung squamous cell carcinoma (LUSC) is often diagnosed at the advanced stage with poor
prognosis. The mechanisms of its pathogenesis and prognosis require urgent elucidation …

TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination

BC Chandler, L Moubadder, CL Ritter… - The Journal of …, 2020 - Am Soc Clin Investig
Increased rates of locoregional recurrence are observed in patients with basal-like breast
cancer (BC) despite the use of radiation therapy (RT); therefore, approaches that result in …

[HTML][HTML] Transcriptional landscape of human cancers

M Li, Q Sun, X Wang - Oncotarget, 2017 - ncbi.nlm.nih.gov
The homogeneity and heterogeneity in somatic mutations, copy number alterations and
methylation across different cancer types have been extensively explored. However, the …

DNA repair inhibitors: potential targets and partners for targeted radionuclide therapy

H Obata, M Ogawa, MR Zalutsky - Pharmaceutics, 2023 - mdpi.com
The present review aims to explore the potential targets/partners for future targeted
radionuclide therapy (TRT) strategies, wherein cancer cells often are not killed effectively …

TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer

JL King, B Zhang, Y Li, KP Li, JJ Ni, HI Saavedra… - Oncogenesis, 2018 - nature.com
Abnormal expression of TTK kinase has been associated with the initiation, progression,
and therapeutic resistance of breast and other cancers, but its roles remain to be clarified. In …

Mitotic checkpoint defects: en route to cancer and drug resistance

S Sarkar, PK Sahoo, S Mahata, R Pal, D Ghosh… - Chromosome …, 2021 - Springer
Loss of mitosis regulation is a common feature of malignant cells that leads to aberrant cell
division with inaccurate chromosome segregation. The mitotic checkpoint is responsible for …

Development of MPS1 inhibitors: recent advances and perspectives

Y Zeng, X Ren, P Jin, Y Zhang, M Zhuo… - Journal of Medicinal …, 2023 - ACS Publications
Monopolar spindle kinase 1 (MPS1) plays a pivotal role as a dual-specificity kinase
governing spindle assembly checkpoint activation and sister chromatid separation in …